BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4209339)

  • 1. [Urinary tract infections due to multiresistant gram negative bacteria].
    Acar JF; Guibert J; Bourquelot P; Brisset JM
    Nouv Presse Med; 1974 Apr; 3(0):69-72. PubMed ID: 4209339
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
    Fraschini F; Scaglione F; Alessandria M; Gattei G
    Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobramycin in the treatment of severe and complicated urinary tract infections.
    Bailey RR; Peddie B
    N Z Med J; 1976 Jul; 84(567):1-3. PubMed ID: 823477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral aminoglycoside antibiotics--1977. Clinical use.
    Simberkoff MS; Rahal JJ
    N Y State J Med; 1977 Jan; 77(1):81-5. PubMed ID: 401973
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of tobramycin and gentamicin].
    Klastersky J; Daneau D; Henri A
    Acta Clin Belg; 1972; 27(5):589-99. PubMed ID: 4205788
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of urinary tract infections with doxycycline. A bacteriological and clinical study].
    Nielsen ML; Gauguin J; Laursen H; Rosenkast P
    Nord Med; 1968 Dec; 79(51):1730-7. PubMed ID: 4976679
    [No Abstract]   [Full Text] [Related]  

  • 7. Tobramycin: clinical and microbiological evaluation.
    Schoutens E; Vanderlinden MP; Yourassowsky E
    Int J Clin Pharmacol; 1973 Nov; 8(3):207-15. PubMed ID: 4589328
    [No Abstract]   [Full Text] [Related]  

  • 8. Tobramycin, a new aminoglycoside antibiotic: Experience in urinary tract infections.
    Landes RR; Melnick I; Hoffman A; Fehrenbaker L
    South Med J; 1975 Jan; 68(1):116-7. PubMed ID: 125452
    [No Abstract]   [Full Text] [Related]  

  • 9. Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
    Naber K; Kees F; Denk K; Bauernfeind A; Grobecker H
    Chemioterapia; 1987 Jun; 6(2 Suppl):517-8. PubMed ID: 3334613
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis].
    Coen G; Nazzaro L; Cipriani P; Giordano A; Mazzaferro S; Petta S; Reale MG; Smacchi A
    Clin Ter; 1989 Feb; 128(4):243-9. PubMed ID: 2524313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ribostamycin in chronic and recurrent bronchopulmonary and urinary infections].
    Abate G; Polimeni RM; Visani G
    Minerva Med; 1980 Feb; 71(4):279-85. PubMed ID: 7354947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibacterial activity of tobramycin].
    Acar JF
    Nouv Presse Med; 1974 Apr; 3(0):57-9. PubMed ID: 4600179
    [No Abstract]   [Full Text] [Related]  

  • 13. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
    Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
    Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The revival of colistin: an old antibiotic for the 21st century].
    Nasnas R; Saliba G; Hallak P
    Pathol Biol (Paris); 2009 May; 57(3):229-35. PubMed ID: 18178335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Data on the effectiveness of a new aminoglycoside antibiotic in the treatment of urinary tract infections].
    Trischitta C; Urso G; Caruso L; Calcara G
    Minerva Urol; 1980; 32(1):49-58. PubMed ID: 7382968
    [No Abstract]   [Full Text] [Related]  

  • 16. Topics in infectious diseases. Current antibiotic sensitivities of gram-negative bacteria.
    Schaffner W; Ratner HB; Koenig MG
    J Tenn Med Assoc; 1972 Jul; 65(7):615-6. PubMed ID: 4671679
    [No Abstract]   [Full Text] [Related]  

  • 17. Newer carbapenems for urinary tract infections.
    Matsumoto T; Muratani T
    Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S35-8. PubMed ID: 15364304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotic sensitivity and immediate clinical response in urinary tract infections].
    Bugnon A; Sakellaridès E; Schelling JL; Bonifas V
    Schweiz Med Wochenschr; 1972 Oct; 102(40):1407-11. PubMed ID: 4567937
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of kasugamycin in urinary tract infection, especially against Pseudomonas aeruginosa].
    Tada S; Hakamada T; Mori O; Yamazaki Y
    Hinyokika Kiyo; 1968 Jan; 14(1):50-6. PubMed ID: 4971183
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of tobramycin in pediatrics. Apropos of 40 cases].
    Gilly R; Fougerat J
    Nouv Presse Med; 1974 Apr; 3(0):72-4. PubMed ID: 4599829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.